Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1926 1
1947 1
1948 1
1950 1
1951 1
1952 4
1953 2
1955 2
1956 1
1959 2
1961 1
1962 1
1963 1
1965 1
1968 1
1969 5
1971 1
1973 2
1975 3
1977 2
1978 7
1979 13
1980 5
1981 6
1982 13
1983 10
1984 18
1985 14
1986 7
1987 9
1988 11
1989 18
1990 25
1991 16
1992 21
1993 18
1994 14
1995 25
1996 11
1997 12
1998 15
1999 15
2000 7
2001 29
2002 15
2003 17
2004 21
2005 19
2006 21
2007 23
2008 22
2009 23
2010 19
2011 29
2012 33
2013 40
2014 37
2015 40
2016 39
2017 33
2018 35
2019 58
2020 49
2021 83
2022 72
2023 41
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

1,069 results

Results by year

Filters applied: . Clear all
Page 1
Cognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): a randomised, controlled, three-arm, parallel group, phase 3, clinical trial.
Kent P, Haines T, O'Sullivan P, Smith A, Campbell A, Schutze R, Attwell S, Caneiro JP, Laird R, O'Sullivan K, McGregor A, Hartvigsen J, Lee DA, Vickery A, Hancock M; RESTORE trial team. Kent P, et al. Among authors: mcgregor a. Lancet. 2023 Jun 3;401(10391):1866-1877. doi: 10.1016/S0140-6736(23)00441-5. Epub 2023 May 2. Lancet. 2023. PMID: 37146623 Clinical Trial.
Sport, exercise and the menstrual cycle: where is the research?
Bruinvels G, Burden RJ, McGregor AJ, Ackerman KE, Dooley M, Richards T, Pedlar C. Bruinvels G, et al. Among authors: mcgregor aj. Br J Sports Med. 2017 Mar;51(6):487-488. doi: 10.1136/bjsports-2016-096279. Epub 2016 Jun 6. Br J Sports Med. 2017. PMID: 27267895 No abstract available.
A review of through-knee amputation.
Panhelleux B, Shalhoub J, Silverman AK, McGregor AH. Panhelleux B, et al. Among authors: mcgregor ah. Vascular. 2022 Dec;30(6):1149-1159. doi: 10.1177/17085381211045183. Epub 2021 Nov 29. Vascular. 2022. PMID: 34844469 Free PMC article. Review.
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Collins AM, Colin-Jones R, Cutland CL, Darton TC, Dheda K, Duncan CJA, Emary KRW, Ewer KJ, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Goodman AL, Green CM, Green CA, Heath PT, Hill C, Hill H, Hirsch I, Hodgson SHC, Izu A, Jackson S, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Lawrie AM, Lelliott A, Libri V, Lillie PJ, Mallory R, Mendes AVA, Milan EP, Minassian AM, McGregor A, Morrison H, Mujadidi YF, Nana A, O'Reilly PJ, Padayachee SD, Pittella A, Plested E, Pollock KM, Ramasamy MN, Rhead S, Schwarzbold AV, Singh N, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Tarrant R, Thomson EC, Török ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Watson MEE, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Voysey M, et al. Among authors: mcgregor a. Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8. Lancet. 2021. PMID: 33306989 Free PMC article. Clinical Trial.
A Painful Breast Mass.
Blundell S, Deshmukh M, McGregor A. Blundell S, et al. Among authors: mcgregor a. Clin Infect Dis. 2022 Dec 19;75(12):2275-2277. doi: 10.1093/cid/ciac250. Clin Infect Dis. 2022. PMID: 36533895 No abstract available.
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
Munro APS, Janani L, Cornelius V, Aley PK, Babbage G, Baxter D, Bula M, Cathie K, Chatterjee K, Dodd K, Enever Y, Gokani K, Goodman AL, Green CA, Harndahl L, Haughney J, Hicks A, van der Klaauw AA, Kwok J, Lambe T, Libri V, Llewelyn MJ, McGregor AC, Minassian AM, Moore P, Mughal M, Mujadidi YF, Murira J, Osanlou O, Osanlou R, Owens DR, Pacurar M, Palfreeman A, Pan D, Rampling T, Regan K, Saich S, Salkeld J, Saralaya D, Sharma S, Sheridan R, Sturdy A, Thomson EC, Todd S, Twelves C, Read RC, Charlton S, Hallis B, Ramsay M, Andrews N, Nguyen-Van-Tam JS, Snape MD, Liu X, Faust SN; COV-BOOST study group. Munro APS, et al. Among authors: mcgregor ac. Lancet. 2021 Dec 18;398(10318):2258-2276. doi: 10.1016/S0140-6736(21)02717-3. Epub 2021 Dec 2. Lancet. 2021. PMID: 34863358 Free PMC article. Clinical Trial.
Nuclear envelope rupture and repair during cancer cell migration.
Denais CM, Gilbert RM, Isermann P, McGregor AL, te Lindert M, Weigelin B, Davidson PM, Friedl P, Wolf K, Lammerding J. Denais CM, et al. Among authors: mcgregor al. Science. 2016 Apr 15;352(6283):353-8. doi: 10.1126/science.aad7297. Epub 2016 Mar 24. Science. 2016. PMID: 27013428 Free PMC article.
1,069 results